Galena Biopharma to Pay $7.5 Million to Settle False Claims Charge

Galena Biopharma will pay more than $7.55 million to resolve allegations that it paid kickbacks to doctors to induce them to prescribe its fentanyl-based drug Abstral. The allegations rose from a whistleblower suit filed under the False Claims Act. Federal officials alleged that Galena Biopharma paid multiple types of kickbacks to induce doctors to prescribe [...]

Advertisements

Novo Nordisk to Pay $58 Million to Settle False Claims Charge

Novo Nordisk will pay $58.65 million to resolve allegations that the company failed to comply with the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) for its Type II diabetes medication Victoza. Novo Nordisk is a subsidiary of Novo Nordisk U.S. Holdings Inc., which is a subsidiary of Novo Nordisk A/S of Denmark. Federal officials alleged [...]

Antibiotic-resistant bacteria in ready-to-eat foods

Research presented at the ASM Microbe 2017 meeting by Bryan Sanchez of California State University-Northridge in Northridge, Calif., show that antibiotic-resistant bacteria are present in many ready-to-eat foods such as fresh produce and dairy products and may serve as a source of human exposure to antibiotic-resistant bacteria. About 2 million people become infected with antibiotic [...]

Woman Killed by a Superbug

Public health officials from Nevada are reporting on a case of a woman who died in Reno in September from an incurable infection. Testing showed the superbug that had spread throughout her system could fend off 26 different antibiotics. The case involved a woman who had spent considerable time in India, where multi-drug-resistant bacteria are [...]

Pharmaceutical Giant Threatens to Drag Government Before Corporate Tribunal

Swiss pharmaceutical giant Novartis appears to have used trade and investment agreements to launch a legal and political pressure campaign against the government of Colombia’s efforts to make a Novartis leukemia drug accessible to cancer patients. The drug, imatinib, also known as Gleevec in the United States, is a chemotherapy medication used to treat several [...]

Getting Patients Hooked On An Opioid Overdose Antidote, Then Raising The Price

First came Martin Shkreli, the brash young pharmaceutical entrepreneur who raised the price for an AIDS treatment by 5,000 percent. Then, Heather Bresch, the CEO of Mylan, who oversaw the price hike for its signature Epi-Pen to more than $600 for a twin-pack, though its active ingredient costs pennies by comparison. Now a small Virginia [...]